haleon plc announces director shareholding update

Published 03/06/2025, 18:06
haleon plc announces director shareholding update

Today, Haleon plc (LSE/NYSE:HLN) reported a transaction involving its Chief Corporate Affairs Officer, Ed Petter, according to a statement based on a press release. The disclosure aligns with the UK Market Abuse Regulation requirements for transactions by Persons Discharging Managerial Responsibilities (PDMRs).

On June 2, 2025, Petter received the vesting of the first tranche of an award of Haleon Ordinary Shares under the Haleon Share Value Plan. This award was part of his remuneration package upon joining Haleon, serving as compensation for incentives forfeited from his previous employment. The award includes provisions for malus and clawback.

The transaction involved the acquisition of 51,584 Ordinary Shares at a price of £0.01 each, with a volume of shares acquired at no cost. Additionally, an automatic disposal of shares occurred to cover tax liabilities, involving 24,305 shares at a price of £4.134623 each. The disposal took place on the London Stock Exchange (LON:LSEG) (XLON).

Haleon, a leader in consumer health, operates in six major categories, including oral health and pain relief, with well-known brands such as Advil and Sensodyne.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.